Determination of soluble vascular endothelial growth factor receptor 3 (sVEGFR-3) in plasma as pharmacodynamic biomarker. [electronic resource]
Producer: 20130207Description: 485-91 p. digitalISSN:- 1873-264X
- Angiogenesis Inhibitors -- administration & dosage
- Biomarkers, Tumor -- blood
- Calibration
- Colorectal Neoplasms -- blood
- Enzyme-Linked Immunosorbent Assay -- standards
- Germany
- Humans
- Indoles -- administration & dosage
- Predictive Value of Tests
- Prospective Studies
- Protein Kinase Inhibitors -- administration & dosage
- Protein Stability
- Pyrroles -- administration & dosage
- Reference Standards
- Reproducibility of Results
- Sunitinib
- Treatment Outcome
- Vascular Endothelial Growth Factor Receptor-3 -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.